🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
If a treated cancer patient cannot make antibodies to a Severe Acute Respir...
Status
Terminated
Location
Compassionate Cancer Care Medical Group
Start Date
2022-06-03
Trial ID
NCT05438498
Treatments Being Tested
This study looks at the safety and effectiveness of AZD7442 in treating COV...
Status
Completed
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Start Date
2021-02-10
Trial ID
NCT05780437
Treatments Being Tested
To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynami...
Status
Completed
Location
Research Site
Start Date
2021-10-09
Trial ID
NCT05437289
Treatments Being Tested
To evaluate the safety and tolerability of a single dose of 600 mg AZD7442 ...
Status
Completed
Location
Research Site
Start Date
2021-12-03
Trial ID
NCT05184062
Treatments Being Tested
Drug studies often look at the effect one or two drugs have on a medical co...
Status
Completed
Location
Pinnacle Research Group (Site 1082), 321 E. 10th Street
Start Date
2020-08-19
Trial ID
NCT04518410
Treatments Being Tested
This study looks at the safety and effectiveness of different drugs in trea...
Status
Completed
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
Start Date
2020-08-04
Trial ID
NCT04501978
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of mRNA CO...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2021-07-09
Trial ID
NCT04952402
This study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD), ...
Status
Completed
Location
Research Site
Start Date
2022-03-21
Trial ID
NCT05281601
Treatments Being Tested
A Phase II Randomized, Open-label, Multicenter, Dose-ranging Study in Adult...
Status
Terminated
Location
Research Site
Start Date
2022-06-09
Trial ID
NCT05375760
AZD3152, a single mAb, is being developed to have broad neutralizing activi...
Status
Completed
Location
Research Site
Start Date
2022-12-16
Trial ID
NCT05648110
Treatments Being Tested